Cargando…
Recent Advances in Age-Related Macular Degeneration Therapies
Age-related macular degeneration (AMD) was described for the first time in the 1840s and is currently the leading cause of blindness for patients over 65 years in Western Countries. This disease impacts the eye’s posterior segment and damages the macula, a retina section with high levels of photorec...
Autores principales: | Fabre, Marie, Mateo, Lou, Lamaa, Diana, Baillif, Stéphanie, Pagès, Gilles, Demange, Luc, Ronco, Cyril, Benhida, Rachid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414333/ https://www.ncbi.nlm.nih.gov/pubmed/36014339 http://dx.doi.org/10.3390/molecules27165089 |
Ejemplares similares
-
New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments
por: Dufies, Maeva, et al.
Publicado: (2019) -
Synthetic accesses to biguanide compounds
por: Grytsai, Oleksandr, et al.
Publicado: (2021) -
Recent advances of exosomes in age-related macular degeneration
por: Gu, Feng, et al.
Publicado: (2023) -
Recent advances in the management and understanding of macular degeneration
por: Bahadorani, Sepehr, et al.
Publicado: (2017) -
Experimental Models in Neovascular Age Related Macular Degeneration
por: Rastoin, Olivia, et al.
Publicado: (2020)